Elevation Oncology, Inc.

NasdaqGS:ELEV Stock Report

Market Cap: US$204.3m

Elevation Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ELEV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Jun 23BuyUS$1,166,613venBio LLCCompany695,002US$1.74
05 Jun 23SellUS$72,070venBio LLCCompany23,570US$3.06

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ELEV?
Owner TypeNumber of SharesOwnership Percentage
Private Companies15,0300.0275%
Individual Insiders980,6331.79%
VC/PE Firms8,707,74415.9%
General Public11,599,69621.2%
Institutions13,546,91724.8%
Hedge Funds19,788,24236.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 129.7%.


Top Shareholders

Top 25 shareholders own 77.31% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.71%
Tang Capital Management, LLC
3,667,600US$13.7m-8.31%1.39%
6.68%
Logos Global Management, L.P.
3,650,000US$13.7m0%1.61%
6.48%
Point72 Asset Management, L.P.
3,540,000US$13.2m0%0.03%
5.67%
Farallon Capital Management, L.L.C.
3,100,000US$11.6m0%0.08%
5.47%
Millennium Management LLC
2,990,279US$11.2m-1.38%0.01%
5.41%
Frazier Life Sciences Management, LP
2,958,579US$11.1m0%0.45%
5.33%
venBio LLC
2,914,255US$10.9m0%3.5%
5.2%
Empery Asset Management, LP
2,840,363US$10.6m0%52.96%
5.19%
Aisling Capital Management LP
2,834,910US$10.6m0%3.94%
4.23%
BVF Partners L.P.
2,312,200US$8.6m0%0.2%
4.22%
Vertex Venture Management Pte. Ltd.
2,307,642US$8.6m0%49.21%
2.75%
OrbiMed Advisors LLC
1,500,000US$5.6m0%0.08%
2.14%
Ikarian Capital, LLC
1,171,939US$4.4m0%1.04%
2.14%
The Vanguard Group, Inc.
1,171,246US$4.4m9.48%no data
1.65%
Sphera Funds Management Ltd
900,000US$3.4m0%0.53%
1.55%
Shawn Leland
846,826US$3.2m0%no data
1.08%
Citadel Advisors LLC
591,483US$2.2m-29.6%no data
1%
Hudson Bay Capital Management LP
546,294US$2.0m0%0.02%
0.91%
Velan Capital Partners LP
497,299US$1.9m0%1.06%
0.82%
Dafna Capital Management, LLC
450,000US$1.7m0%0.38%
0.81%
Renaissance Technologies LLC
441,490US$1.7m0%no data
0.67%
Two Sigma Investments, LP
364,892US$1.4m-16.8%no data
0.47%
Boothbay Fund Management, LLC
256,715US$960.1k0%0.04%
0.42%
Geode Capital Management, LLC
230,136US$860.7k0%no data
0.28%
Bank of America Corporation, Asset Management Arm
154,469US$577.7k0.01%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.